Incyte Corporation (INCY) Covered Calls

Incyte Corporation is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

You can sell covered calls on Incyte Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for INCY (prices last updated Fri 4:16 PM ET):

Incyte Corporation (INCY) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
100.07	-1.01	99.00	100.88	1.8M	17	20

Covered Calls For Incyte Corporation (INCY)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Feb 20	100	3.30	97.58	2.5%	41.5%
Mar 20	100	5.60	95.28	5.0%	36.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

Incyte Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of proprietary small molecule drugs to treat serious unmet medical needs. The company's product, Jakafi (ruxolitinib), a JAK1 and JAK2 inhibitor, is currently approved in the U.S. for the treatment of intermediate or high-risk myelofibrosis and is in development as a potential treatment for other cancers. Incyte was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.

Top 10 Open Interest For Feb 20 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	QQQ covered calls	1.	BE covered calls
2.	SLV covered calls	7.	EWZ covered calls	2.	OCUL covered calls
3.	KWEB covered calls	8.	CORZ covered calls	3.	SMCI covered calls
4.	GLD covered calls	9.	INTC covered calls	4.	WDC covered calls
5.	IBIT covered calls	10.	SPY covered calls	5.	IREN covered calls

Want more examples? INCR Covered Calls | INDA Covered Calls